P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA

por Duminuco, A., Romano, A., Leotta, D., La Spina, E., Cambria, D., Bulla, A., Del Fabro, V., Tibullo, D., Giallongo, C., Palumbo, G.A., Conticello, C., Di Raimondo, F.
Publicado 2023

MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes

por Giallongo, C., Dulcamare, I., Giallongo, S., Duminuco, A., Pieragostino, D., Cufaro, M. C., Amorini, A. M., Lazzarino, G., Romano, A., Parrinello, N., Di Rosa, M., Broggi, G., Caltabiano, R., Caraglia, M., Scrima, M., Pasquale, L. S., Tathode, M. S., Li Volti, G., Motterlini, R., Di Raimondo, F., Tibullo, D., Palumbo, G. A.
Publicado 2023

P931: PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY OF GAUCHER DISEASE PREVALENCE IN PATIENTS AFFECTED BY MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

por Giuffrida, G., Markovic, U., Conticello, C., Nicolosi, D., Calafiore, V., Romano, A., Condorelli, A., Grasso, S., Duminuco, A., Calagna, M., Nardo, A., Riccobene, C., Esposito, B., Consoli, U., Di Giacomo, V., Neri, S., Cingari, M. R., Iaria, G., Innao, V., Spina, M., Gentile, J., Zizzo, C., Duro, G., Di Raimondo, F.
Publicado 2022